Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection-Reference-Cited by-同舟云学术

Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection

Published:2015-02 Issue:2 Volume:22 Page:285-292
ISSN:1074-5521
Container-title:Chemistry & Biology
language:en
Short-container-title:Chemistry & Biology

Author:

Hansson Magnus Joakim,Moss Steven James,Bobardt Michael,Chatterji Udayan,Coates Nigel,Garcia-Rivera Jose A.,Elmér Eskil,Kendrew Steve,Leyssen Pieter,Neyts Johan,Nur-E-Alam Mohammad,Warneck Tony,Wilkinson Barrie,Gallay Philippe,Gregory Matthew Alan

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,General Medicine,Biochemistry

Reference53 articles.

1. Mutasynthesis of fluorinated pactamycin analogues and their antimalarial activity;Almabruk;Org. Lett.,2013

2. Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals;An;PLoS Genet.,2007

3. Alisporivir (Deb025) treatment can be associated with transient, reversible and manageable hyperbilirubinemia, without signs of hepatoxicity: analysis of the Novartis clinical database;Avila;J. Hepatol.,2012

4. Target cell cyclophilins facilitate human papillomavirus type 16 infection;Bienkowska-Haba;PLoS Pathog.,2009

5. Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus;Bobardt;Proc. Natl. Acad. Sci. USA,2008

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclophilin inhibition as a strategy for the treatment of human disease;Frontiers in Pharmacology;2024-07-08

2. Cyclophilin D knockout significantly prevents HCC development in a streptozotocin-induced mouse model of diabetes-linked NASH;PLOS ONE;2024-04-04

3. Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging viruses;European Journal of Medicinal Chemistry;2024-02

4. The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity;Viruses;2023-10-17

5. The Cyclophilin Inhibitor Rencofilstat Decreases HCV-induced Hepatocellular Carcinoma Independently of Its Antiviral Activity;2023-08-20